Could a sedative used in ICUs finally give PTSD patients restful sleep?
NCT ID NCT06685965
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 32 times
Summary
This study tests whether a medication called RE03 (dexmedetomidine), already used in hospitals, can improve sleep quality in people with PTSD who struggle with sleep disturbances like nightmares. About 24 adults with PTSD will receive either the drug or a placebo in a random order to compare effects. The goal is to find a better treatment for sleep problems that current PTSD therapies often fail to address.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTTRAUMATIC STRESS DISORDER (PTSD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Human Sleep Pharmacology, University of Zurich
RECRUITINGZurich, Canton of Zurich, 8057, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.